Legionnaires’ disease in Europe, 2011
This surveillance report is based on Legionnaires’ disease surveillance data for 2011. The surveillance is carried out by the European Legionnaires’ Disease Surveillance Network (ELDSNet) and coordinated by ECDC. The surveillance data are from two different schemes: the first covers all cases reported from European Union Member States, Iceland and Norway; and the second scheme covers all travel-associated cases of Legionnaires’ disease, both foreign and domestic travel, including reports from countries outside the EU.
In 2011, a total of 4 897 cases of Legionnaires’ disease (LD) were notified by EU Member States, Iceland and Norway, with a 22% decrease compared to the previous year. Most of the cases (67%) were community-acquired, while 24% were travel-associated and 7% were linked with healthcare facilities. With this decrease, the notification rate of all cases of Legionnaires’ disease in the EU/EEA in 2011 has reached the lowest level since 2004.
The surveillance activities were carried out by the European Legionnaires’ Disease Surveillance Network (ELDSNet) and coordinated by ECDC. Data were collected through two different schemes: the first scheme covers all cases of LD reported from ELDSNet members, while the second scheme covers all reported cases of travel-associated Legionnaires’ disease (TALD), including reports from countries outside the EU. This is the third annual report presenting LD data and the second to also include all reported cases of TALD.
Legionnaires’ disease is a multisystem disease involving pneumonia. Humans are infected by inhalation of aerosols containing Legionella bacteria. The diagnosis relies on specific laboratory tests, and the disease is considered to be widely underreported, mainly because it is under diagnosed by clinicians and under-notified to national authorities.
The ELDSNet will continue its efforts to improve notification in countries where under-ascertainment probably remains quite high, especially by raising awareness, providing laboratory support and training, and evaluating the surveillance systems in place.
HIV/AIDS surveillance in Europe 2019 - 2018 data
28 Nov 2019 - This report has been published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe. The Regional Office developed the overview of the European Region as a whole and validated the figures of the non-member countries of the European Union (EU)/European Economic Area (EEA) and ECDC developed the overview of the EU/EEA countries and validated the EU/EEA figures.
Smallpox - Annual Epidemiological Report for 2018
13 Nov 2019 - Smallpox was declared eradicated in 1980. There were no reports of confirmed or possible smallpox in the EU/EEA or other countries for 2018.
Tularaemia Annual Epidemiological Report for 2018
12 Nov 2019 - For 2018, 18 countries in the EU/EEA reported 441 cases of tularaemia, 358 (81%) of which were confirmed. The EU/EEA notification rate for 2018 was 0.07 cases per 100 000 population. The male-to-female ratio was 1.7:1. As in previous years, the notification rate among males was higher in most age groups except for the age groups between 5 and 24 years. Notification rates increased with age and peaked at 45–64 years.